White Paper – Nano Particulate Formulations
|
|
|
The most common reason for producing sub-micron or nano-sized dispersions is to increase oral bioavailability of poorly soluble drugs. In this white paper, Alliance Contract Pharma, an Altasciences company, explains how other routes of administration can also benefit from the smaller format. Alliance Contract Pharma joined the Altasciences family in February 2020. We offer 25 years of experience in pharmaceutical manufacturing and laboratory operations in a wide range of dosage forms. |
The Solution to Shorter SEND Timelines
|
|
|
Are you currently experiencing challenges with SEND, specifically when it comes to timelines? You can rely on Altasciences to ask the right questions from the get-go, to smoothly guide you through the SEND process and help you avoid potential delays in the preparation of reliable SEND datasets for your regulatory submissions. |
|
|
|
|
Contact our SEND team today to experience the difference. |
|
|
Microsampling Benefits
|
|
|
As an alternative to traditional venipuncture, blood microsampling represents a less invasive and simplified collection technique, resulting in numerous benefits for preclinical and clinical studies alike. Recent advances in device technology, specifically the Mitra® VAMS® microsampler manufactured by Neoteryx, has enabled Altasciences to fully support blood microsampling programs. With over 12 Mitra® VAMS® assays validated for a range of drug applications and study types, we look forward to sharing our combined expertise in support of your next microsampling program. |
|
|
|
|
Choosing the Right CRO for Your Clinical Trial Monitoring
|
|
|
At Altasciences, we understand your clinical trials are unique and require careful management. As part of our partnership with you, our highly experienced CRAs offer top quality monitoring, through agile and flexible processes and transparent communication. We are up to date with all required trainings, and remain abreast of current legislations, techniques, and technologies. For more information on Altasciences' monitoring capabilities, contact one of our experienced CRA team members. |
Towards a Universal Bioanalytical Workflow for VAMS
Quantitation of the Monoclonal Antibody Rituximab Using VAMS, Impact-Assisted Extraction, Trypsin Digestion and LC-MRM
The Right Strategy for your Small Molecule Program
|
|
|
Did you know that, in addition to large molecule work, Altasciences' preclinical team has extensive experience in designing and conducting safety assessment programs for small molecules? Our solutions meet all regulatory requirements, and include IND/NDA-enabling toxicology, safety pharmacology, and laboratory services in both rodent and non-rodent species. Choose Altasciences for your small molecule safety assessment program and let us guide you seamlessly through each milestone. |
|
|
|
Stability of ASO in Tissue Matrix
Resolving Issues with Matrix Effect Oligonucleotides